Journal
JOURNAL OF CLINICAL MEDICINE
Volume 9, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/jcm9061651
Keywords
coronavirus disease 2019; COVID-19; thrombosis; hemostasis; microparticles; endothelium; antiphospholipid antibodies
Categories
Ask authors/readers for more resources
The coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare communities across the globe on an unprecedented scale. Patients have had diverse clinical outcomes, but those developing COVID-19-related coagulopathy have shown a disproportionately worse outcome. This narrative review summarizes current evidence regarding the epidemiology, clinical features, known and presumed pathophysiology-based models, and treatment guidance regarding COVID-19 coagulopathy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
